These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9933654)
1. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China. Tian JH; Zhang JM; Hou QT; Oyang QH; Wang JM; Luan ZS; Chuan L; He YJ Eur J Nucl Med; 1999 Jan; 26(1):2-7. PubMed ID: 9933654 [TBL] [Abstract][Full Text] [Related]
2. Samarium-153 ethylenediamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases. Tripathi M; Singhal T; Chandrasekhar N; Kumar P; Bal C; Jhulka PK; Bandopadhyaya G; Malhotra A Indian J Cancer; 2006; 43(2):86-92. PubMed ID: 16790946 [TBL] [Abstract][Full Text] [Related]
3. A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Resche I; Chatal JF; Pecking A; Ell P; Duchesne G; Rubens R; Fogelman I; Houston S; Fauser A; Fischer M; Wilkins D Eur J Cancer; 1997 Sep; 33(10):1583-91. PubMed ID: 9389919 [TBL] [Abstract][Full Text] [Related]
4. The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain. Liepe K; Runge R; Kotzerke J J Cancer Res Clin Oncol; 2005 Jan; 131(1):60-6. PubMed ID: 15449184 [TBL] [Abstract][Full Text] [Related]
5. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. Anderson PM; Wiseman GA; Dispenzieri A; Arndt CA; Hartmann LC; Smithson WA; Mullan BP; Bruland OS J Clin Oncol; 2002 Jan; 20(1):189-96. PubMed ID: 11773169 [TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer. Dolezal J; Vizda J; Odrazka K Urol Int; 2007; 78(1):50-7. PubMed ID: 17192733 [TBL] [Abstract][Full Text] [Related]
8. A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases. Turner JH; Claringbold PG; Hetherington EL; Sorby P; Martindale AA J Clin Oncol; 1989 Dec; 7(12):1926-31. PubMed ID: 2585026 [TBL] [Abstract][Full Text] [Related]
9. Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases. Thapa P; Nikam D; Das T; Sonawane G; Agarwal JP; Basu S J Nucl Med; 2015 Oct; 56(10):1513-9. PubMed ID: 26315829 [TBL] [Abstract][Full Text] [Related]
10. Samarium-153 lexidronam for painful bone metastases. Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284 [No Abstract] [Full Text] [Related]
11. Comparative analysis of patients not responding to a single dose of 153Sm-EDTMP palliative treatment for painful skeletal metastases. Tian J; Cao L; Zhang J; Ouyang Q; Hou Q; He Y Chin Med J (Engl); 2002 Jun; 115(6):824-8. PubMed ID: 12123545 [TBL] [Abstract][Full Text] [Related]
12. [153Sm-EDTMP for moderate and severe bone cancer pain]. Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058 [TBL] [Abstract][Full Text] [Related]
13. Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone. Alberts AS; Smit BJ; Louw WK; van Rensburg AJ; van Beek A; Kritzinger V; Nel JS Radiother Oncol; 1997 May; 43(2):175-9. PubMed ID: 9192964 [TBL] [Abstract][Full Text] [Related]
14. Samarium-153-EDTMP in bone metastases. Ahonen A; Joensuu H; Hiltunen J; Hannelin M; Heikkilä J; Jakobsson M; Jurvelin J; Kairemo K; Kumpulainen E; Kulmala J J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):123-7. PubMed ID: 7543288 [TBL] [Abstract][Full Text] [Related]
15. Samarium-153-labelled EDTMP for bone metastases from cancer of the prostate. Sandeman TF; Budd RS; Martin JJ Clin Oncol (R Coll Radiol); 1992 May; 4(3):160-4. PubMed ID: 1375094 [TBL] [Abstract][Full Text] [Related]
16. [Primary investigation of dose-effect relationship of 153Sm-EDTMP in treating multiple bone metastases]. Fan W; Chen LX; Liu XW; Tang Q; Wang GH; Zhi SF; Zeng ZY Ai Zheng; 2006 Nov; 25(11):1395-8. PubMed ID: 17094908 [TBL] [Abstract][Full Text] [Related]
17. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. Serafini AN; Houston SJ; Resche I; Quick DP; Grund FM; Ell PJ; Bertrand A; Ahmann FR; Orihuela E; Reid RH; Lerski RA; Collier BD; McKillop JH; Purnell GL; Pecking AP; Thomas FD; Harrison KA J Clin Oncol; 1998 Apr; 16(4):1574-81. PubMed ID: 9552068 [TBL] [Abstract][Full Text] [Related]
18. ESR dosimetry of 89Sr and 153Sm in bone. Kinoshita A; Braga FJ; Graeff CF; Baffa O Appl Radiat Isot; 2001 Feb; 54(2):269-74. PubMed ID: 11200888 [TBL] [Abstract][Full Text] [Related]
19. Treatment of bone pain secondary to metastases using samarium-153-EDTMP. Etchebehere EC; Pereira Neto CA; Lima MC; Santos Ade O; Ramos CD; Silva CM; Camargo EE Sao Paulo Med J; 2004 Sep; 122(5):208-12. PubMed ID: 15558143 [TBL] [Abstract][Full Text] [Related]
20. 153Sm-EDTMP for bone pain palliation in skeletal metastases. Maini CL; Bergomi S; Romano L; Sciuto R Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S171-8. PubMed ID: 15127241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]